James M. Gower

2013

In 2013, James M. Gower earned a total compensation of $1.7M as Former Chief Executive Officer, Chairman of the Board and Director at Rigel Pharmaceuticals, a 26% decrease compared to previous year.

Compensation breakdown

Option Awards$1,004,850
Salary$695,118
Other$9,906
Total$1,709,874

Gower received $1M in option awards, accounting for 59% of the total pay in 2013.

Gower also received $695.1K in salary and $9.9K in other compensation.

Rankings

In 2013, James M. Gower's compensation ranked 4,440th out of 12,286 executives tracked by ExecPay. In other words, Gower earned more than 63.9% of executives.

ClassificationRankingPercentile
All
4,440
out of 12,286
64th
Division
Manufacturing
1,522
out of 4,612
67th
Major group
Chemicals And Allied Products
432
out of 1,466
71st
Industry group
Drugs
298
out of 1,160
74th
Industry
Pharmaceutical Preparations
238
out of 890
73rd
Source: SEC filing on March 30, 2015.

Gower's colleagues

We found four more compensation records of executives who worked with James M. Gower at Rigel Pharmaceuticals in 2013.

2013

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, of Discovery and Research

2013

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2013

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2013

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

In-depth

You may also like